Continuing podiatric medical education questionnaire

Continuing podiatric medical education questionnaire

CONTINUING PODIATRIC MEDICAL EDUCATION QUESTIONNAIRE The Journal of Foot & Ankle Surgery Continuing Podiatric Medical Education (CPME) program is inte...

283KB Sizes 3 Downloads 62 Views

CONTINUING PODIATRIC MEDICAL EDUCATION QUESTIONNAIRE The Journal of Foot & Ankle Surgery Continuing Podiatric Medical Education (CPME) program is intended to be an 18-credit-per-year program. Each issue will have 10 questions of Board Examination quality in a five-part (A-E), multiple-choice format. Participants will receive a maximum of 3 credits per issue for each correctly completed CPME Answer Form submitted by Data Trace Publishing Company for scoring. There is a fee of $15.00 per issue ($12.00 for ACFAS members) for scoring and processing, payable in advance. Please make checks payable to Data Trace Publishing Company. All applicants for credit must be current subscribers to The Journal of Foot & Ankle Surgery or current members of ACFAS in good standing. Participants must pass the written examination material in order to receive credit, but may request one retake (within 90 days of receipt of results) of any issue for which they did not receive credit initially. A passing grade is 70% correct. The fee for a retake exam is $5.00, payable in advance. The Journal of Foot & Ankle Surgery will notify state boards of participants' credits only in those states that require such notification from a sponsoring organization; in most states it will be the responsibility of the individual to report CPME credit to the state boards in a timely manner. Data Trace Publishing Company and The Journal of Foot & Ankle Surgery are approved sponsors of continuing education programs by the Council on Podiatric Medical Education (CPME). The following states have approved The Journal of Foot & Ankle Surgery program for credit. AK(18), AL(l8), AR(l8), AZ(l8), CA(l8), CO(3/issue, 18/year), DC(18), DE(l8), FL(8Ibiennium), GA(l8), HI(l8), ID(3/issue, 6/year), MA( 18), MD( IOlbiennium), ME( 18), MI(l8), MN(l8), MO(6), ND(6), NE(l8), NH(l8), NM(l), NV(l8), NY(3/issue, max. 15/triennium, Class A credits), OH(l8/lIBlbiennium), OK(5), OR(l8), RI(18), SC(18), SD(l8), UT(l8), WA(lO), WI(l8). INSTRUCTiONS: The following question are based on the material presented in the journal issue. Please select the best answer and mark the appropriate box with an X on the CPME Answer Form which follows. The Answer Form should be returnedfor scoring to Data Trace Publishing Company, P.G. Box 1239, Brooklandville, MD 21022-9978.

CPME QUESTIONS I. Which of the following is true regarding epidermal inclusion cysts?

The Journal of Foot & Ankle Surgery 1067-2516/99/3804-0308$4.00/0 Copyright © 1999 by the American College of Foot and Ankle Surgeons

308

THE JOURNAL OF FOOT & ANKLE SURGERY

A. They are formed by the displacement of epithelial cells to the epidermal layer. B. They are most common in the lower extremities. C. They can be congenitaL D. Malignant transformation does not occur. E. Spontaneous involution is common.

2. Which of the following is true regarding primary lymphoma of bone? A. It is found most commonly in the upper extremity. B. Pathologic feature is not seen because of the slow enlargement. C. Constitutional symptoms are a hallmark of its presence. D. It usually occurs in the metaphyseal region of bone. E. Amputation is the most common treatment. 3. Which of the following qualities do not contribute to the visibility of glass in a radiograph? A. B. C. D. E.

Color Size Lead content Density Titanium

4. Which of the following is not a predisposing factor to contracting onychomycosis? A. B. C. D. E.

Age Occlusive foot wear HlV infection Immunosuppressive medications Sex

5. The most common infective organism of onychomycosis is which of the following? A. Trichophyton mentagrophytes B. Microsporum nanum C. Fungoidis pedum D. Trichophyton rubrum E. Epidermophyton fioccosum

6. Which of the following is true regarding oral antifungal agents? A. There are few incidences of side effects. B. The effectiveness of pulsed therapy may depend on the agent. C. Hepatotoxicity is the most common side effect. D. They cannot be used to treat tinea pedis. E. Efficacy is improved with adjunctive topical therapy.

6. Which of the following is not true regarding dystonias of the lower extremity? A. B. C. D.

They can be inherited. Fixed deformities can occur. They can be secondary to focal brain lesions. Neurosurgical intervention is quite effective in treatment. E. The presentation is quite variable.

7. Routine callus removal has been shown to: A. B. C. D. E.

Reduce plantar pressures Diminish the incidence of ulceration Increase tensile forces in plantar skin All of the above A and B only

8. Which of the following is true regarding the use of pneumatic tourniquets? A. The lowest pressure that will occlude arterial inflow is the safest. B. Complications from tourniquet use are often catastrophic.

C. Local metabolic disturbances from ischemia are most common complications. D. Body fat composition and limb circumference have no bearing on tourniquet pressure. E. A minimum of 250 mm Hg is necessary to occlude blood flow at the ankle. 9. According to Massey et aI., which of the following was (were) a valuable predictor(s) of an effective occlusive pressure? A. B. C. D. E.

Mean arterial pressure Anklelbrachial index Systolic blood pressure Body mass Band C

10. Which of the following factors may contribute to the effective occlusive pressure for tourniquet use? A. B. C. D. E.

General health of the patient Presence of peripheral arterial disease Presence of varicose veins All of above A and C

VOLUME 38, NUMBER 4, JULY/AUGUST 1999

309